Aristides Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Aristides Capital's HAE Position: Q3 2026 in Review
Aristides Capital opened a new position in Haemonetics (HAE) in Q3 2026: 3,388 shares worth $357K. The stake represents 0.05% of the portfolio and ranks #174 among its holdings. This is a return to the name: Aristides Capital previously reported a position in HAE as recently as Q1 2020.
Aristides Capital first reported a position in HAE in Q4 2019 and has held it in 3 quarters since. The position peaked at $519K in Q4 2019. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Aristides Capital held 3,388 shares of Haemonetics worth $357K as of Q3 2026.
- Haemonetics was a new Aristides Capital position in Q3 2026.
- Haemonetics made up 0.05% of Aristides Capital's portfolio in Q3 2026, its #174 holding.
- Aristides Capital first reported a position in Haemonetics in Q4 2019 and has held it in 3 quarters since.
- Aristides Capital's Haemonetics position peaked at $519K in Q4 2019.
- 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Aristides Capital's 13F filing for Q3 2026, filed 16 Nov 2026.